The United States comes in last when it comes to healthcare quality, despite it coming first in spending, according to a new report published Monday by the Commonwealth Fund, a foundation whose goal, according to its website, is "to promote a high-performing healthcare system."
Teva Pharmaceutical Industries on Thursday announced that the U.S. Court of Appeals for the Federal Circuit upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb's entecavir compound claim of U.S. Patent No. 5,206,244 invalid.
The House Energy and Commerce Committee on Tuesday advanced bipartisan legislation sponsored by full committee vice chair Marsha Blackburn to address the nation’s growing prescription drug abuse epidemic.
Ohio Gov. John Kasich on Monday signed executive order 2014-04K authorizing licensed pharmacists to administer the measles, mumps, and rubella (MMR) vaccine to individuals 18 years and older in order to provide those adults who have not yet received this vaccination with additional opportunities to obtain the MMR vaccine.
New York Gov. Andrew Cuomo last week announced an agreement between New York State and GW Pharmaceuticals to develop clinical trials using an active ingredient derived from the marijuana plant to help treat children diagnosed with epilepsy who suffer from seizures and other medical complications.
In an effort to help ensure clean waterways, Illinois Gov. Pat Quinn has signed legislation to make Illinois the first state in the nation to ban the manufacture and sale of personal care products containing synthetic plastic microbeads.
Canada’s Federal court ruled recently that the country’s Patented Medicine Prices Review Board – a federal tribunal that regulates pricing on branded medicines – could not extend price control measures to cover generic drug companies.